E83.39

Other disorders of phosphorus metabolism

E83.39 is a specific clinical classification within the ICD-10-CM system representing various metabolic disturbances of phosphorus that are not classified under more specific codes like familial hypophosphatemia or hypophosphatasia. Phosphorus is a critical intracellular anion involved in skeletal mineralization, cellular energy production via Adenosine Triphosphate (ATP), and the structural integrity of cell membranes through phospholipids. This category encompasses acquired conditions such as those resulting from renal tubular defects, phosphate-wasting syndromes, and nutritional deficiencies. Clinically, disorders of phosphorus metabolism can manifest as hypophosphatemia (low serum levels) or hyperphosphatemia (high serum levels), each with distinct pathophysiological consequences. Chronic hypophosphatemia often leads to impaired mineralization of the bone matrix, resulting in osteomalacia in adults and rickets in children. Hyperphosphatemia is most commonly associated with advanced chronic kidney disease or hypoparathyroidism and can lead to secondary hyperparathyroidism and systemic soft tissue calcification. Management typically focuses on addressing the underlying etiology, whether it be dietary, renal, or endocrine, and correcting the mineral balance through supplementation or phosphate binders.

Clinical Symptoms

  • Generalized muscle weakness
  • Proximal myopathy
  • Bone pain and tenderness
  • Skeletal deformities (e.g., bowing of legs)
  • Pathologic fractures
  • Delayed growth in pediatric patients
  • Confusion and irritability
  • Seizures
  • Paresthesias
  • Respiratory failure due to diaphragmatic weakness
  • Cardiac arrhythmias
  • Hemolytic anemia
  • Leukocyte dysfunction
  • Ectopic calcification of soft tissues (in hyperphosphatemic states)

Common Causes

  • Acquired renal phosphate wasting syndromes
  • Adult-onset Fanconi syndrome
  • Chronic alcoholism and alcohol withdrawal
  • Refeeding syndrome in severely malnourished individuals
  • Excessive use of aluminum- or magnesium-containing antacids
  • Vitamin D deficiency or vitamin D resistance
  • Post-renal transplant phosphorus wasting
  • Heavy metal poisoning (e.g., cadmium or lead)
  • Tumor-induced osteomalacia (oncogenic osteomalacia)
  • Primary hyperparathyroidism
  • Chronic parenteral nutrition with inadequate phosphate replacement

Documentation & Coding Tips

Explicitly identify the specific phosphorus abnormality as either hypophosphatemia or hyperphosphatemia and document the underlying etiology.

Example: Assessment: Chronic hyperphosphatemia (E83.39) secondary to Stage 4 Chronic Kidney Disease (N18.4). Patient presents with serum phosphorus of 5.8 mg/dL despite adherence to a low-phosphate diet. Risk Adjustment: This identifies a metabolic complication of CKD, supporting higher severity in HCC 136 (Chronic Kidney Disease, Stage 4). Billing Focus: Clear linkage between the metabolic disorder and the primary renal diagnosis supports medical necessity for frequent lab monitoring.

Billing Focus: Document etiology-manifestation relationships clearly using terms like secondary to or due to.

Document the acuity and duration of the phosphorus disorder to differentiate between transient and persistent conditions.

Example: Assessment: Acute severe hypophosphatemia (E83.39) in the setting of refeeding syndrome following prolonged malnutrition. Serum phosphorus is 1.1 mg/dL. Billing Focus: Acute status justifies intensive inpatient monitoring and parenteral replacement. Risk Adjustment: Distinguishing acute metabolic derangements from chronic states helps define the patient's immediate physiologic instability.

Billing Focus: Specify acute vs. chronic status to justify level of care and service intensity.

Detail the clinical manifestations associated with the phosphorus disorder such as muscle weakness, respiratory failure, or cardiac arrhythmias.

Example: Plan: Patient with hypophosphatemia (E83.39) exhibiting generalized proximal muscle weakness and diaphragmatic fatigue. Respiratory therapy consulted for weaning support. Risk Adjustment: Documenting systemic manifestations of metabolic disorders provides evidence of condition severity. Billing Focus: Clinical symptoms support the medical necessity for high-complexity Evaluation and Management (E/M) services.

Billing Focus: Link symptoms directly to the phosphorus level to support the medical decision-making complexity.

Clarify when phosphorus disorders are a result of therapeutic interventions such as medications or total parenteral nutrition (TPN).

Example: Assessment: Medication-induced hypophosphatemia (E83.39) likely secondary to heavy antacid use and recent initiation of tenofovir. Risk Adjustment: Identifying iatrogenic causes provides a complete clinical picture for risk assessment. Billing Focus: Supports the necessity for medication reconciliation and potential therapeutic substitution services.

Billing Focus: Identify external causes or drug-induced mechanisms to ensure accurate ICD-10 coding and support for pharmacy-related services.

Document the impact of phosphorus disorders on bone health or mineral metabolism, especially in elderly or osteoporotic patients.

Example: Assessment: Oncogenic osteomalacia presenting as persistent hypophosphatemia (E83.39) and multiple pathologic fractures. Billing Focus: Supports the medical necessity for advanced imaging (e.g., PET-CT) to locate FGF-23 secreting tumors. Risk Adjustment: Linking metabolic disorders to skeletal pathology captures the full scope of chronic disease management.

Billing Focus: Documenting skeletal impact justifies dual-energy X-ray absorptiometry (DXA) and other diagnostic bone studies.

Relevant CPT Codes

Related Diagnoses

Hierarchy